• Importing medicine from Canada's or other countries' drug supplies isn't safe or cost-effective.

  • More than a decade into the counterfeit pill crisis, fake prescription pills made with deadly ingredients are still killing Americans. 

  • Overwhelming demand for transformative GLP-1s has led to widespread illicit compounding and a boom in counterfeiting.

  • Several states are trying to to set price caps to reduce the cost of expensive medicine, but this could bankrupt pharmacies and threaten patient access.

Prescription Drug Freight Fraud Report, October 2025

October 15, 2025

What large-scale commercial imports made it into the country between March and August of 2025?

Oregon State Pharmacy Association makes the case for PBM reform, not payment limits

October 7, 2025

This summer, Brian Mayo, Executive Director of the Oregon State Pharmacy Association (OSPA), made the case for pharmacy benefit manager (PBM) reform as a better way to rein in drug prices.

October 7, 2025: PSM shares prescription drug freight fraud findings with Democratic governors

October 7, 2025

PSM Executive Director Shabbir Safdar is speaking at the Democratic Governors Association about the threat of unregulated prescription drugs smuggled into the U.S.

Why are price cap proposals on medicines dangerous to pharmacies and patients?

September 30, 2025

Supply chain complexity means that upper payment limits and Medicare maximum fair prices will fall disproportionately on pharmacies, leading to closures that threaten patient access to care.

September 30, 2025: Florida agency requests $4 million more for $132 million empty warehouse

September 30, 2025

Although the state won FDA approval for its importation program in January 2024, it has yet to implement the program.

Med spas need stronger regulation

September 26, 2025

Medical spas and wellness clinics are operating on the edge of existing regulatory frameworks and it’s a risk to American patients.

September 22, 2025: Chinese executives sentenced for shipping 200 kilos of fentanyl precursors into the U.S.

September 23, 2025

Between November 2022 and June 2023, Amarvel Biotech sold over 200 kilograms of precursor chemicals to U.S. buyers with full knowledge that they would be used to make fentanyl.

Like your information on video? Subscribe to our YouTube playlist!

youtube-video-thumbnail

Regulatory confusion leaves med spa patients at risk. Learn more.

youtube-video-thumbnail

Gaps in FDA oversight of 503B compounding facilities put patients at risk.

youtube-video-thumbnail

More fake Ozempic in the U.S. Learn more.

Click the images below to see more recent videos.